Funding
Overview
The Starr Cancer Consortium is intended largely to support critical mass, collaborative projects with the potential for transforming impact on the understanding and treatment of cancer, through the development and systematic application of molecular technologies.The goal of the Starr Cancer Consortium is to support collaborative research in three areas: technology, disease applications, and basic biology:
- Technology. To drive the development of technology for molecular characterization of cancer through collaborative research among the participating institutions of the Starr Cancer Consortium.
- Disease Applications. To apply new molecular technologies in collaborative projects directed at diverse cancers, in the process gaining a deeper understanding of the molecular basis of these cancers and defining new paradigms for cancer research, diagnosis and treatment.
- Basic Biology. To accelerate collaborative research of the basic biological mechanisms underlying the development of cancers.
The Starr Cancer Consortium seeks proposals for funding through a Request for Applications (RFA) mechanism.
The Request for Applications is available here [PDF]
Schedule
Letters of Intent
Applicants should submit a Letter of Intent (LOI) prior to submission of an application.
Letters of Intent must include:
- Project title
- PI and Co-PI(s) names, affiliations and contact information
- Collaborator(s) name(s) and affiliation(s)
- Brief statement of topic and scope
LOIs should be sent as Word or pdf documents to SCC@mskcc.org
The deadline for letters of intent is April 12, 2012
Application
Applicants must use the SCC application template.
Completed applications must be submitted via the Application Submission page.
The deadline for application submission is June 18, 2012 at 5:00PM
Contact
For further information contact:Paizhe Pressley
Program Coordinator
Starr Cancer Consortium
Phone: 212 639 7434
presslep@mskcc.org